Oguz Kelemen Selected Research

Neuregulins

9/2014	Neuregulin 1-induced AKT and ERK phosphorylation in patients with fragile X syndrome (FXS) and intellectual disability associated with obstetric complications.
1/2011	The relationship among neuregulin 1-stimulated phosphorylation of AKT, psychosis proneness, and habituation of arousal in nonclinical individuals.
7/2010	Neuregulin 1-induced AKT phosphorylation in monozygotic twins discordant for schizophrenia.
4/2010	Suppression of the P50 evoked response and neuregulin 1-induced AKT phosphorylation in first-episode schizophrenia.
12/2009	Neuregulin 1-stimulated phosphorylation of AKT in psychotic disorders and its relationship with neurocognitive functions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oguz Kelemen Research Topics

Disease

17	Schizophrenia (Dementia Praecox) 02/2020 - 06/2005
9	Psychotic Disorders (Schizoaffective Disorder) 03/2019 - 01/2006
2	Parkinson Disease (Parkinson's Disease) 01/2017 - 01/2017
2	Fragile X Syndrome (Martin Bell Syndrome) 09/2014 - 12/2013
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2014 - 12/2013
1	Tobacco Use Disorder (Nicotine Dependence) 10/2021
1	Intellectual Disability (Idiocy) 09/2014
1	Hypoxia (Hypoxemia) 09/2014
1	Premature Birth (Birth, Premature) 09/2014
1	Major Depressive Disorder (Major Depressive Disorders) 08/2014
1	Inflammation (Inflammations) 08/2014
1	Mental Disorders (Mental Disorder) 01/2009

Drug/Important Bio-Agent (IBA)

9	Neuregulin-1 (Neuregulin 1)IBA 01/2017 - 04/2009
5	Antipsychotic Agents (Antipsychotics)IBA 03/2019 - 01/2006
5	NeuregulinsIBA 09/2014 - 12/2009
4	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2017 - 08/2014
2	Levodopa (L Dopa)FDA LinkGeneric 01/2017 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2017 - 01/2017
2	Messenger RNA (mRNA)IBA 05/2014 - 12/2013
2	Fragile X Mental Retardation ProteinIBA 12/2013 - 10/2013
2	gamma-Aminobutyric Acid (GABA)IBA 12/2013 - 10/2013
2	N 30IBA 05/2007 - 07/2005
1	Antidepressive Agents (Antidepressants)IBA 10/2021
1	Dexfenfluramine (Redux)IBA 02/2020
1	Olanzapine (Zyprexa)FDA Link 05/2017
1	Risperidone (Risperdal Consta)FDA LinkGeneric 05/2017
1	CytokinesIBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2014
1	Interleukin-6 (Interleukin 6)IBA 08/2014
1	C-Reactive ProteinIBA 08/2014
1	Tacrolimus Binding Proteins (FKBP)IBA 05/2014
1	EnzymesIBA 12/2013
1	ImmunosorbentsIBA 12/2013
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 12/2013
1	RNA (Ribonucleic Acid)IBA 12/2013
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 12/2013
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 10/2013
1	Phosphatidylinositols (Phosphatidylinositol)IBA 03/2012
1	Phosphotransferases (Kinase)IBA 03/2012
1	Protein Isoforms (Isoforms)IBA 04/2009
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2009
1	Dopamine D3 ReceptorsIBA 06/2005
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 06/2005

Therapy/Procedure

2	Shamanism 01/2014 - 01/2007
1	Therapeutics 02/2006